These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 18349088)

  • 21. Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.
    Bounafaa A; Berrougui H; Ghalim N; Nasser B; Bagri A; Moujahid A; Ikhlef S; Camponova P; Yamoul N; Simo OK; Essamadi A; Khalil A
    PLoS One; 2015; 10(8):e0133719. PubMed ID: 26241956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.
    Voetsch B; Benke KS; Panhuysen CI; Damasceno BP; Loscalzo J
    Arch Neurol; 2004 Mar; 61(3):351-6. PubMed ID: 15023811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1(R192) from PON1(Q192).
    Nakanishi M; Takanami Y; Maruyama T; Murata M; Motohashi Y; Nakano S; Uchida K; Maruyama C; Kyotani S; Tsushima M
    J Atheroscler Thromb; 2003; 10(6):337-42. PubMed ID: 15037822
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rogić D; Rako I; Radić Antolić M; Beriša M; Rumora L
    J Clin Pathol; 2018 Nov; 71(11):963-970. PubMed ID: 29858231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms.
    Haj Mouhamed D; Ezzaher A; Mechri A; Neffati F; Omezzine A; Bouslama A; Gaha L; Douki W; Najjar MF
    Environ Health Prev Med; 2012 Jul; 17(4):316-21. PubMed ID: 22205545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase 1 Gene L55M Polymorphism and Paraoxonase 1 Activity in Obstructive Sleep Apnea Patients.
    Płóciniczak A; Baszczuk A; Ludziejewska A; Winiarska H; Michalak S; Kasprzak G; Formanowicz D; Cofta S; Wysocka E
    Adv Exp Med Biol; 2019; 1150():17-24. PubMed ID: 30244352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the relationship of paraoxonase-1 Q192R polymorphisms and the severity of lung disease in SM-exposed patients.
    Golmanesh L; Bahrami F; Pourali F; Vahedi E; Wahhabaghai H; Mehrani H; Ghanei M
    Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):419-25. PubMed ID: 23672526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase-1 gene Q192R polymorphism and reactive oxygen metabolites.
    Kotani K; Tsuzaki K; Sakane N
    J Int Med Res; 2012; 40(4):1513-8. PubMed ID: 22971504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.
    Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL
    Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
    Ramírez-Jiménez R; Martínez-Salazar MF; Almenares-López D; Yáñez-Estrada L; Monroy-Noyola A
    Metab Syndr Relat Disord; 2018 Mar; 16(2):90-96. PubMed ID: 29393817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?
    Davis KA; Crow JA; Chambers HW; Meek EC; Chambers JE
    Environ Health Perspect; 2009 Aug; 117(8):1226-31. PubMed ID: 19672401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.
    Kennedy DJ; Tang WH; Fan Y; Wu Y; Mann S; Pepoy M; Hazen SL
    J Am Heart Assoc; 2013 Apr; 2(2):e000104. PubMed ID: 23557751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
    Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.
    Souza-Nogueira A; Camargo AE; Remondi FA; Paoliello MM; Richter RJ; Furlong CE; Barbosa DS; Maes M; Moreira EG
    Arch Endocrinol Metab; 2016 Oct; 60(5):426-435. PubMed ID: 27812605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.